1. Home
  2. CRDO vs VTRS Comparison

CRDO vs VTRS Comparison

Compare CRDO & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRDO
  • VTRS
  • Stock Information
  • Founded
  • CRDO 2008
  • VTRS 1961
  • Country
  • CRDO Cayman Islands
  • VTRS United States
  • Employees
  • CRDO N/A
  • VTRS 32000
  • Industry
  • CRDO Semiconductors
  • VTRS Medicinal Chemicals and Botanical Products
  • Sector
  • CRDO Technology
  • VTRS Health Care
  • Exchange
  • CRDO Nasdaq
  • VTRS Nasdaq
  • Market Cap
  • CRDO 7.8B
  • VTRS 11.0B
  • IPO Year
  • CRDO 2022
  • VTRS N/A
  • Fundamental
  • Price
  • CRDO $44.70
  • VTRS $9.10
  • Analyst Decision
  • CRDO Strong Buy
  • VTRS Hold
  • Analyst Count
  • CRDO 10
  • VTRS 4
  • Target Price
  • CRDO $71.40
  • VTRS $10.50
  • AVG Volume (30 Days)
  • CRDO 7.2M
  • VTRS 15.3M
  • Earning Date
  • CRDO 03-04-2025
  • VTRS 02-27-2025
  • Dividend Yield
  • CRDO N/A
  • VTRS 5.16%
  • EPS Growth
  • CRDO N/A
  • VTRS N/A
  • EPS
  • CRDO 0.03
  • VTRS N/A
  • Revenue
  • CRDO $327,532,000.00
  • VTRS $14,739,300,000.00
  • Revenue This Year
  • CRDO $106.05
  • VTRS N/A
  • Revenue Next Year
  • CRDO $57.02
  • VTRS $0.99
  • P/E Ratio
  • CRDO $1,541.33
  • VTRS N/A
  • Revenue Growth
  • CRDO 99.38
  • VTRS N/A
  • 52 Week Low
  • CRDO $16.82
  • VTRS $8.77
  • 52 Week High
  • CRDO $86.69
  • VTRS $13.55
  • Technical
  • Relative Strength Index (RSI)
  • CRDO 39.14
  • VTRS 30.72
  • Support Level
  • CRDO $38.70
  • VTRS $9.25
  • Resistance Level
  • CRDO $47.58
  • VTRS $9.74
  • Average True Range (ATR)
  • CRDO 5.55
  • VTRS 0.36
  • MACD
  • CRDO -0.88
  • VTRS -0.05
  • Stochastic Oscillator
  • CRDO 27.84
  • VTRS 20.29

About CRDO Credo Technology Group Holding Ltd

Credo Technology Group Holding Ltd delivers high-speed solutions to break bandwidth barriers on every wired connection in the data infrastructure market. It provides secure, high-speed connectivity solutions that deliver improved power and cost efficiency as data rates and corresponding bandwidth requirements increase exponentially throughout the data infrastructure market. It has a geographic presence in Hong Kong, the United States, Mainland China, Taiwan, and the Rest of the World.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: